CG Oncology (CGON) Other Gross PP&E Adjustments (2023 - 2026)
CG Oncology posted quarterly Other Gross PP&E Adjustments of $12.9 million for Q1 2026, up 1344.53% year-on-year from $889977.8 in Q1 2025, and up 57.16% on a QoQ basis from $8.2 million in Q4 2025.
CG Oncology (CGON) has 4 years of Other Gross PP&E Adjustments data on file, last reported at $12.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 1344.53% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 1344.53% YoY), and the FY2025 full-year result was $8.2 million, up 5827.54% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at $12.9 million, up from $8.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $12.9 million in Q1 2026 and bottomed at -$1.0 million in Q1 2025.
- The 4-year median for Other Gross PP&E Adjustments is -$302000.0 (2024), against an average of $2.9 million.
- Peak annual rise in Other Gross PP&E Adjustments reached 5827.54% in 2025, while the deepest fall reached 193.31% in 2025.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$422000.0 in 2023, then surged by 132.7% to $138000.0 in 2024, then surged by 5827.54% to $8.2 million in 2025, then surged by 57.16% to $12.9 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at $12.9 million (Q1 2026), $8.2 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 12.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.86 Mn |
| Mar 31, 2026 | 12.86 Mn |
| Dec 31, 2025 | 8.18 Mn |
| Dec 31, 2025 | 8.18 Mn |
| Sep 30, 2025 | 11.71 Mn |
| Sep 30, 2025 | 11.71 Mn |
| Jun 30, 2025 | -965,000.00 |
| Jun 30, 2025 | -965,000.00 |
| Mar 31, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | -275,000.00 |
| Sep 30, 2024 | -275,000.00 |
| Jun 30, 2024 | -329,000.00 |
| Jun 30, 2024 | -329,000.00 |
| Mar 31, 2024 | -368,000.00 |
| Mar 31, 2024 | -368,000.00 |
| Dec 31, 2023 | -422,000.00 |
| Dec 31, 2023 | -422,000.00 |